The model of care tested in the GPS project aims to optimize pharmacotherapy for seniors undergoing cognitive assessment or suffering from major neurocognitive disorder (MCND) at home. The goal is to reduce polymedication, inappropriate medications and the treatment burden of seniors and to maintain their cognitive health, quality of life and autonomy. The intervention will include knowledge exchange sessions with nurses, pharmacists, and doctors in FMGs, and increased collaboration between these professionals and home care services teams. Other goal is to increase the satisfaction of the seniors, their families, and the professionals involved in the GPS project.
All seniors (65 years of age or older) undergoing cognitive evaluation OR referred to a memory clinic OR having been diagnosed with cognitive impairment within the last year OR with MCND and followed up at home AND,
referred to the pharmacist, for the FMGs exposed
taking prescription medications
Seniors in palliative care OR
unable to answer questionnaires in French AND without a caregiver.
CHU de Quebec-Universite Laval
Lead sponsor
CISSS de Chaudière-Appalaches
Collaborator
Ciusss de L'Est de l'Île de Montréal
Collaborator
Fonds de la Recherche en Santé du Québec
Collaborator